Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,181,431
- Total 13F value
- $44,013,000
- Share change
- -93,582
- SEC-reported price per share
- $7.12
- Number of holders
- 13
- Value change
- -$199,957
- Number of buys
- 6
- Number of sells
- 4
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
Who this page is about.
1 source field
Report period
Q1 2021
Institutions
13
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
9/9
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 146%
Showing 1-6 of 9 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 146%.
9 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
146%
Johnson & Johnson Innovation - JJ...
134%
MMCAP International Inc. SPC
43%
RTW INVESTMENTS, LP
38%
MILLENNIUM MANAGEMENT LLC
29%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 9 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
146%
|
$14,760,000
2,313,489 shares
|
— | 31 Dec 2020 |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
134%
|
$13,611,000
2,133,402 shares
|
— | 31 Dec 2020 |
| MMCAP International Inc. SPC |
13F
Company
|
43%
|
$4,367,000
684,451 shares
|
— | 31 Dec 2020 |
| RTW INVESTMENTS, LP |
13F
Company
|
38%
|
$3,828,000
600,000 shares
|
— | 31 Dec 2020 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
29%
|
$2,935,000
460,047 shares
|
— | 31 Dec 2020 |
| Taylor Wealth Management Partners |
13F
Company
|
2.4%
|
$247,000
38,752 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
6,181,431
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
9
Q1 2021 holders
13
Holder diff
4
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend